Advertisement

FDA Approves Inlexzo for Bladder Cancer

0

First and only drug releasing system is indicated for patients with BCG-unresponsive non-muscle-invasive bladder cancer seeking bladder preservation

Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder

0

Dose-dependent effect seen compared with placebo

Timely Opioid Administration Cuts Hospitalizations for Pediatric Sickle Cell Crises

0

Findings seen for first administration within 60 minutes for children presenting to the emergency department with a sickle cell crisis

FDA Releases Guidance to Promote Nonopioid Alternatives for Chronic Pain

0

New guidance aims to increase nonopioid choices for chronic pain while combating misuse

Half of Women With Hyperemesis Gravidarum Report Major Impacts on Life

0

Antiemetic use and outcomes vary widely for this group of patients

WHO Updates List of Essential Medicines to Include GLP-1s

0

PD-1/PD-L1 immunotherapies for several metastatic cancers also made the list of essential drugs

2000 to 2023 Saw Rise in Pediatric Exposure to Medications, Supplements

0

Overall rate of exposure for children aged 6 to 12 years up by 53.8 percent; >300 percent increase in exposure linked to self-harm, suicidal intent

One in 10 Undergoing Early Cancer Surgery Have New Persistent Opioid Use

0

Persons in the highest quartile of morphine milligram equivalents exposure have increased risk for new persistent opioid use

Baxdrostat Reduces Seated Systolic BP in Uncontrolled, Resistant Hypertension

0

Addition of baxdrostat to background therapy results in significantly lower seated systolic blood pressure

FDA Expands Use of Vonvendi for Von Willebrand Disease

0

The recombinant treatment is now approved for prophylactic use in adults and for treating bleeding episodes and perioperative use in children